TreeWAS – Variant ID: rs34972666

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K65.0 Acute peritonitis	0.000	0.970	0.030
K65 Peritonitis	0.000	0.975	0.025
K65.9 Peritonitis, unspecified	0.000	0.975	0.025
D50.9 Iron deficiency anaemia, unspecified	0.022	0.978	0.000
M23.23 Derangement of meniscus due to old tear or injury (Medial collateral ligament or Other and unspecified medial meniscus)	0.020	0.980	0.000
R10.2 Pelvic and perineal pain	0.000	0.980	0.020
K65.8 Other peritonitis	0.000	0.982	0.018
K90.0 Coeliac disease	0.000	0.983	0.017
K90 Intestinal malabsorption	0.000	0.987	0.013
K70.9 Alcoholic liver disease, unspecified	0.000	0.987	0.013
K90.9 Intestinal malabsorption, unspecified	0.000	0.988	0.012
K70 Alcoholic liver disease	0.000	0.989	0.011
N50.8 Other specified disorders of male genital organs	0.010	0.990	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.990	0.010
K90.8 Other intestinal malabsorption	0.000	0.990	0.009
K90.3 Pancreatic steatorrhoea	0.000	0.990	0.009
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.990	0.009
K90.1 Tropical sprue	0.000	0.990	0.009
K70.3 Alcoholic cirrhosis of liver	0.000	0.991	0.009
K70.4 Alcoholic hepatic failure	0.000	0.991	0.009
K70.1 Alcoholic hepatitis	0.000	0.991	0.009
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.992	0.008
K70.0 Alcoholic fatty liver	0.000	0.993	0.007
I67.9 Cerebrovascular disease, unspecified	0.007	0.993	0.000
K70-K77 Diseases of liver	0.000	0.993	0.007
K75 Other inflammatory liver diseases	0.000	0.994	0.006
K73 Chronic hepatitis, not elsewhere classified	0.000	0.994	0.006
I67.1 Cerebral aneurysm, nonruptured	0.006	0.994	0.000
K65-K67 Diseases of peritoneum	0.000	0.994	0.006
I67 Other cerebrovascular diseases	0.006	0.994	0.000
K75.9 Inflammatory liver disease, unspecified	0.000	0.994	0.006
K75.0 Abscess of liver	0.000	0.994	0.006
G83.8 Other specified paralytic syndromes	0.005	0.995	0.000
G83.4 Cauda equina syndrome	0.005	0.995	0.000
G83 Other paralytic syndromes	0.005	0.995	0.000
K73.9 Chronic hepatitis, unspecified	0.000	0.995	0.005
O26.8 Other specified pregnancy-related conditions	0.000	0.995	0.005
K77 Liver disorders in diseases classified elsewhere	0.000	0.995	0.005
K71 Toxic liver disease	0.000	0.995	0.005
G83.1 Monoplegia of lower limb	0.005	0.995	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.995	0.005
I61 Intracerebral haemorrhage	0.005	0.995	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.005	0.995	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.995	0.004
K75.2 Nonspecific reactive hepatitis	0.000	0.995	0.004
K75.1 Phlebitis of portal vein	0.000	0.995	0.004
I67.0 Dissection of cerebral arteries, nonruptured	0.004	0.995	0.000
K72 Hepatic failure, not elsewhere classified	0.000	0.995	0.005
N18.4 Chronic kidney disease, stage 4	0.005	0.995	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.995	0.004
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.995	0.004
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.995	0.004
G83.9 Paralytic syndrome, unspecified	0.004	0.996	0.000
K67 Disorders of peritoneum in infectious diseases classified elsewhere	0.000	0.996	0.004
K74 Fibrosis and cirrhosis of liver	0.000	0.996	0.004
I67.7 Cerebral arteritis, not elsewhere classified	0.004	0.996	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.004	0.996	0.000
I67.5 Moyamoya disease	0.004	0.996	0.000
I67.4 Hypertensive encephalopathy	0.004	0.996	0.000
I67.3 Progressive vascular leukoencephalopathy	0.004	0.996	0.000
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.996	0.004
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.004	0.996	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.004	0.996	0.000
I60-I69 Cerebrovascular diseases	0.004	0.996	0.000
I65.2 Occlusion and stenosis of carotid artery	0.004	0.996	0.000
K75.4 Autoimmune hepatitis	0.000	0.996	0.004
G83.5 Locked-in syndrome	0.004	0.996	0.000
G83.3 Monoplegia, unspecified	0.004	0.996	0.000
G83.0 Diplegia of upper limbs	0.004	0.996	0.000
G83.2 Monoplegia of upper limb	0.004	0.996	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.004	0.996	0.000
K74.0 Hepatic fibrosis	0.000	0.996	0.004
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.004	0.996	0.000
D50 Iron deficiency anaemia	0.004	0.996	0.000
K75.8 Other specified inflammatory liver diseases	0.000	0.996	0.004
K76.8 Other specified diseases of liver	0.000	0.996	0.004
K71.9 Toxic liver disease, unspecified	0.000	0.996	0.004
K71.8 Toxic liver disease with other disorders of liver	0.000	0.996	0.004
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.996	0.004
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.996	0.004
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.996	0.004
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.996	0.004
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.996	0.004
K71.2 Toxic liver disease with acute hepatitis	0.000	0.996	0.004
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.996	0.004
K71.0 Toxic liver disease with cholestasis	0.000	0.996	0.004
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.996	0.004
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.996	0.004
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.004	0.996	0.000
I67.2 Cerebral atherosclerosis	0.004	0.996	0.000
K74.3 Primary biliary cirrhosis	0.000	0.996	0.004
K76 Other diseases of liver	0.000	0.996	0.004
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.004	0.996	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.004	0.996	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.004	0.996	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.004	0.996	0.000
I61.8 Other intracerebral haemorrhage	0.003	0.996	0.000
K72.1 Chronic hepatic failure	0.000	0.996	0.003
K67.8 Other disorders of peritoneum in infectious diseases classified elsewhere	0.000	0.997	0.003
K67.3 Tuberculous peritonitis	0.000	0.997	0.003
K67.2 Syphilitic peritonitis	0.000	0.997	0.003
K67.1 Gonococcal peritonitis	0.000	0.997	0.003
K67.0 Chlamydial peritonitis	0.000	0.997	0.003
K74.4 Secondary biliary cirrhosis	0.000	0.997	0.003
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.997	0.003
K74.1 Hepatic sclerosis	0.000	0.997	0.003
K72.0 Acute and subacute hepatic failure	0.000	0.997	0.003
I62 Other nontraumatic intracranial haemorrhage	0.003	0.997	0.000
D73.0 Hyposplenism	0.003	0.997	0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.003	0.997	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.003	0.997	0.000
I65.1 Occlusion and stenosis of basilar artery	0.003	0.997	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.003	0.997	0.000
M94.88 Other specified disorders of cartilage (Other)	0.003	0.997	0.000
K76.6 Portal hypertension	0.000	0.997	0.003
I68 Cerebrovascular disorders in diseases classified elsewhere	0.003	0.997	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.003	0.997	0.000
Y43.3 Other antineoplastic drugs	0.003	0.997	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.003	0.997	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.003	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
K72.9 Hepatic failure, unspecified	0.000	0.997	0.003
I69 Sequelae of cerebrovascular disease	0.003	0.997	0.000
D50.1 Sideropenic dysphagia	0.003	0.997	0.000
K76.7 Hepatorenal syndrome	0.000	0.997	0.003
K76.5 Hepatic veno-occlusive disease	0.000	0.997	0.003
K76.4 Peliosis hepatis	0.000	0.997	0.003
K76.3 Infarction of liver	0.000	0.997	0.003
K76.2 Central haemorrhagic necrosis of liver	0.000	0.997	0.003
K76.1 Chronic passive congestion of liver	0.000	0.997	0.003
Y43 Primarily systemic agents	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.003	0.997	0.000
X58.9 Unspecified place	0.003	0.997	0.000
I60 Subarachnoid haemorrhage	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
M48.02 Spinal stenosis (Cervical region)	0.000	0.997	0.003
I62.1 Nontraumatic extradural haemorrhage	0.003	0.997	0.000
S62.30 Fracture of other metacarpal bone (closed)	0.003	0.997	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.997	0.003
M94.8 Other specified disorders of cartilage	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.003	0.997	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.003	0.997	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.003	0.997	0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery	0.002	0.997	0.000
I66.8 Occlusion and stenosis of other cerebral artery	0.002	0.997	0.000
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.002	0.997	0.000
I66.3 Occlusion and stenosis of cerebellar arteries	0.002	0.997	0.000
I66.2 Occlusion and stenosis of posterior cerebral artery	0.002	0.997	0.000
I66.1 Occlusion and stenosis of anterior cerebral artery	0.002	0.997	0.000
I66.0 Occlusion and stenosis of middle cerebral artery	0.002	0.997	0.000
I68.8 Other cerebrovascular disorders in diseases classified elsewhere	0.002	0.997	0.000
I68.2 Cerebral arteritis in other diseases classified elsewhere	0.002	0.997	0.000
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
I68.0 Cerebral amyloid angiopathy	0.002	0.997	0.000
H26.8 Other specified cataract	0.000	0.997	0.003
K52.8 Other specified non-infective gastro-enteritis and colitis	0.003	0.997	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.003	0.997	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.997	0.000
M94.86 Other specified disorders of cartilage (Lower leg)	0.002	0.997	0.000
I67.8 Other specified cerebrovascular diseases	0.003	0.997	0.000
S67.0 Crushing injury of thumb and other finger(s)	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.997	0.000
I69.3 Sequelae of cerebral infarction	0.002	0.997	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.002	0.997	0.000
O26 Maternal care for other conditions predominantly related to pregnancy	0.000	0.997	0.002
M70.22 Olecranon bursitis-Upper arm	0.000	0.998	0.002
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.998	0.002
M43.1 Spondylolisthesis	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
X58 Exposure to other specified factors	0.002	0.998	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
M89 Other disorders of bone	0.002	0.998	0.000
M87.97 Osteonecrosis, unspecified (Ankle and foot)	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.002	0.998	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.002	0.998	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.002	0.998	0.000
I60.4 Subarachnoid haemorrhage from basilar artery	0.002	0.998	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.002	0.998	0.000
M89.5 Osteolysis	0.002	0.998	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.002	0.998	0.000
M87.9 Osteonecrosis, unspecified	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
M89.55 Osteolysis (Pelvic region and thigh)	0.002	0.998	0.000
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
I60.8 Other subarachnoid haemorrhage	0.002	0.998	0.000
L29.2 Pruritus vulvae	0.002	0.998	0.000
Y00.9 Unspecified place	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
M89.8 Other specified disorders of bone	0.002	0.998	0.000
O26.2 Pregnancy care of habitual aborter	0.000	0.998	0.002
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.002	0.998	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.002	0.998	0.000
M94.84 Other specified disorders of cartilage (Hand)	0.002	0.998	0.000
M94.83 Other specified disorders of cartilage (Forearm)	0.002	0.998	0.000
M94.82 Other specified disorders of cartilage (Upper arm)	0.002	0.998	0.000
M94.81 Other specified disorders of cartilage (Shoulder region)	0.002	0.998	0.000
M94.80 Other specified disorders of cartilage (Multiple sites)	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
M86 Osteomyelitis	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.998	0.002
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
G80 Infantile cerebral palsy	0.002	0.998	0.000
M87 Osteonecrosis	0.002	0.998	0.000
M87.96 Osteonecrosis, unspecified (Lower leg)	0.002	0.998	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.002	0.998	0.000
O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium	0.000	0.998	0.002
X58-X59 Accidental exposure to other and unspecified factors	0.002	0.998	0.000
Y00 Assault by blunt object	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
D86.0 Sarcoidosis of lung	0.000	0.998	0.002
M89.3 Hypertrophy of bone	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
M86.8 Other osteomyelitis	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
Y95 Nosocomial condition	0.002	0.998	0.000
V20-V29 Motorcycle rider injured in transport accident	0.002	0.998	0.000
E11.5 With peripheral circulatory complications	0.002	0.998	0.000
O26.6 Liver disorders in pregnancy, childbirth and the puerperium	0.000	0.998	0.002
O26.5 Maternal hypotension syndrome	0.000	0.998	0.002
O26.4 Herpes gestationis	0.000	0.998	0.002
O26.3 Retained intra-uterine contraceptive device in pregnancy	0.000	0.998	0.002
O26.1 Low weight gain in pregnancy	0.000	0.998	0.002
O26.0 Excessive weight gain in pregnancy	0.000	0.998	0.002
Y57.6 Other diagnostic agents	0.002	0.998	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.002	0.998	0.000
M86.4 Chronic osteomyelitis with draining sinus	0.002	0.998	0.000
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
M43.19 Spondylolisthesis (Site unspecified)	0.002	0.998	0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.15 Spondylolisthesis (Thoracolumbar region)	0.002	0.998	0.000
M43.14 Spondylolisthesis (Thoracic region)	0.002	0.998	0.000
M43.13 Spondylolisthesis (Cervicothoracic region)	0.002	0.998	0.000
M43.12 Spondylolisthesis (Cervical region)	0.002	0.998	0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.10 Spondylolisthesis (Multiple sites in spine)	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
Y00-Y09 Assault	0.002	0.998	0.000
M87.91 Osteonecrosis, unspecified (Shoulder region)	0.002	0.998	0.000
H50.1 Divergent concomitant strabismus	0.000	0.998	0.002
X58.8 Other specified place	0.002	0.998	0.000
X58.0 Home	0.002	0.998	0.000
X58.7 Farm	0.002	0.998	0.000
X58.6 Industrial and construction area	0.002	0.998	0.000
X58.5 Trade and service area	0.002	0.998	0.000
X58.4 Street and highway	0.002	0.998	0.000
X58.3 Sports and athletics area	0.002	0.998	0.000
X58.2 School, other institution and public administrative area	0.002	0.998	0.000
X58.1 Residential institution	0.002	0.998	0.000
Chapter XX External causes of morbidity and mortality	0.002	0.998	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.002	0.998	0.000
M89.6 Osteopathy after poliomyelitis	0.002	0.998	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.002	0.998	0.000
M89.2 Other disorders of bone development and growth	0.002	0.998	0.000
M89.1 Epiphyseal arrest	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
G80.9 Infantile cerebral palsy, unspecified	0.002	0.998	0.000
M86.9 Osteomyelitis, unspecified	0.002	0.998	0.000
G81 Hemiplegia	0.002	0.998	0.000
D23.7 Skin of lower limb, including hip	0.000	0.998	0.002
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
M86-M90 Other osteopathies	0.002	0.998	0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.002	0.998	0.000
M86.47 Chronic osteomyelitis with draining sinus (Ankle and foot)	0.002	0.998	0.000
M87.8 Other osteonecrosis	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
D27 Benign neoplasm of ovary	0.000	0.998	0.002
M43 Other deforming dorsopathies	0.002	0.998	0.000
V28 Motorcycle rider injured in noncollision transport accident	0.002	0.998	0.000
M86.86 Other osteomyelitis (Lower leg)	0.002	0.998	0.000
M89.59 Osteolysis (Site unspecified)	0.002	0.998	0.000
M89.58 Osteolysis (Other)	0.002	0.998	0.000
M89.57 Osteolysis (Ankle and foot)	0.002	0.998	0.000
M89.56 Osteolysis (Lower leg)	0.002	0.998	0.000
M89.54 Osteolysis (Hand)	0.002	0.998	0.000
M89.53 Osteolysis (Forearm)	0.002	0.998	0.000
M89.52 Osteolysis (Upper arm)	0.002	0.998	0.000
M89.51 Osteolysis (Shoulder region)	0.002	0.998	0.000
M89.50 Osteolysis (Multiple sites)	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
M87.99 Osteonecrosis, unspecified (Site unspecified)	0.002	0.998	0.000
M87.98 Osteonecrosis, unspecified (Other)	0.002	0.998	0.000
M87.94 Osteonecrosis, unspecified (Hand)	0.002	0.998	0.000
M87.93 Osteonecrosis, unspecified (Forearm)	0.002	0.998	0.000
M87.92 Osteonecrosis, unspecified (Upper arm)	0.002	0.998	0.000
M87.90 Osteonecrosis, unspecified (Multiple sites)	0.002	0.998	0.000
M86.6 Other chronic osteomyelitis	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.002	0.998	0.000
M86.94 Osteomyelitis, unspecified (Hand)	0.002	0.998	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.002	0.998	0.000
M89.88 Other specified disorders of bone (Other)	0.002	0.998	0.000
M89.84 Other specified disorders of bone (Hand)	0.002	0.998	0.000
M89.83 Other specified disorders of bone (Forearm)	0.002	0.998	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.002	0.998	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.002	0.998	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.002	0.998	0.000
G80.1 Spastic diplegia	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
V40-V49 Car occupant injured in transport accident	0.002	0.998	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.002	0.998	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.002	0.998	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.998	0.002
V28.2 Unspecified motorcycle rider injured in nontraffic accident	0.002	0.998	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.002	0.998	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.002	0.998	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
D86 Sarcoidosis	0.000	0.998	0.002
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.002	0.998	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.002	0.998	0.000
W75-W84 Other accidental threats to breathing	0.002	0.998	0.000
M86.87 Other osteomyelitis (Ankle and foot)	0.002	0.998	0.000
I24.8 Other forms of acute ischaemic heart disease	0.002	0.998	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.002	0.998	0.000
M86.5 Other chronic haematogenous osteomyelitis	0.002	0.998	0.000
M86.3 Chronic multifocal osteomyelitis	0.002	0.998	0.000
M86.2 Subacute osteomyelitis	0.002	0.998	0.000
M86.1 Other acute osteomyelitis	0.002	0.998	0.000
M86.0 Acute haematogenous osteomyelitis	0.002	0.998	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.000	0.998	0.002
S62.3 Fracture of other metacarpal bone	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
V27 Motorcycle rider injured in collision with fixed or stationary object	0.002	0.998	0.000
X47 Accidental poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
X50-X57 Overexertion, travel and privation	0.002	0.998	0.000
M62.88 Other specified disorders of muscle (Other)	0.002	0.998	0.000
M87.85 Other osteonecrosis (Pelvic region and thigh)	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.002	0.998	0.000
M89.98 Disorder of bone, unspecified (Other)	0.002	0.998	0.000
D86.1 Sarcoidosis of lymph nodes	0.000	0.998	0.002
G80.8 Other infantile cerebral palsy	0.002	0.998	0.000
G80.4 Ataxic cerebral palsy	0.002	0.998	0.000
G80.3 Dyskinetic cerebral palsy	0.002	0.998	0.000
G80.2 Infantile hemiplegia	0.002	0.998	0.000
G80.0 Spastic cerebral palsy	0.002	0.998	0.000
M43.6 Torticollis	0.002	0.998	0.000
M87.3 Other secondary osteonecrosis	0.002	0.998	0.000
M87.1 Osteonecrosis due to drugs	0.002	0.998	0.000
M87.0 Idiopathic aseptic necrosis of bone	0.002	0.998	0.000
S72.10 Pertrochanteric fracture (closed)	0.002	0.998	0.000
M43.2 Other fusion of spine	0.002	0.998	0.000
R40.0 Somnolence	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
M89.39 Hypertrophy of bone (Site unspecified)	0.002	0.998	0.000
M89.38 Hypertrophy of bone (Other)	0.002	0.998	0.000
M89.36 Hypertrophy of bone (Lower leg)	0.002	0.998	0.000
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.002	0.998	0.000
M89.34 Hypertrophy of bone (Hand)	0.002	0.998	0.000
M89.33 Hypertrophy of bone (Forearm)	0.002	0.998	0.000
M89.32 Hypertrophy of bone (Upper arm)	0.002	0.998	0.000
M89.31 Hypertrophy of bone (Shoulder region)	0.002	0.998	0.000
M89.30 Hypertrophy of bone (Multiple sites)	0.002	0.998	0.000
G81.9 Hemiplegia, unspecified	0.002	0.998	0.000
M62.8 Other specified disorders of muscle	0.002	0.998	0.000
Y00.8 Other specified place	0.002	0.998	0.000
Y00.4 Street and highway	0.002	0.998	0.000
Y00.2 School, other institution and public administrative area	0.002	0.998	0.000
Y00.7 Farm	0.002	0.998	0.000
Y00.6 Industrial and construction area	0.002	0.998	0.000
Y00.5 Trade and service area	0.002	0.998	0.000
Y00.3 Sports and athletics area	0.002	0.998	0.000
Y00.1 Residential institution	0.002	0.998	0.000
Y00.0 Home	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
K66 Other disorders of peritoneum	0.000	0.998	0.002
V98-V99 Other and unspecified transport accidents	0.002	0.998	0.000
V70-V79 Bus occupant injured in transport accident	0.002	0.998	0.000
M86.89 Other osteomyelitis (Site unspecified)	0.002	0.998	0.000
M86.88 Other osteomyelitis (Other)	0.002	0.998	0.000
M86.85 Other osteomyelitis (Pelvic region and thigh)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations